Ryan Specialty Holdings, Inc.
NYSE:RYANInsurance - Specialty
-$0.59 today
- Market cap
- $5.79B
- Beta
- 0.64
- P/E (TTM)
- 34.2
- EPS (TTM)
- $1.02
- Dividend yield
- 1.44%
Volume 1.38M
Average 2.89M
RYAN Investing Cash Flow
Net cash used in or generated by investments in assets, acquisitions, and securities.
Ryan Specialty Holdings, Inc.NYSE: RYAN
Investing Cash Flow · Q2 FY2026 · quarter ended Jun 2026
Investing cash flow declines year over year
Q2 FY2026 investing cash flow of $18.72M (cash outflow) fell 59.2% year over year, ahead of the -88.4% change in trailing-twelve-month investing cash flow. Sequentially, it rose 41.1% from the prior quarter. Over 3 fiscal years it compounded at +233.8% a year.
Context
- Investing cash flow amounted to 27.3% of revenue in FY2025, down 42.5 pp from a year earlier.
- Investing cash flow grew in size in 2 of the last 3 fiscal years.
What to watch
Whether quarterly growth of -59.2% holds above the trailing-twelve-month pace of -88.4%.
Sources:Cash FlowText generated from reported figures; not investment advice.
Investing Cash Flow history
USD · from the cash flow
- Latest · FY2025
- (834.01M) USD
- Year-over-year change
- +52.5%
| Period | Period end | Investing Cash Flow | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | (834.01M) | +52.5% |
| FY2024 | 2024-12-31 | (1.76B) | -268.7% |
| FY2023 | 2023-12-31 | (476.23M) | -2024.1% |
| FY2022 | 2022-12-31 | (22.42M) | +95.1% |
| FY2021 | 2021-12-31 | (457.94M) | — |
Investing Cash Flow vs competitors
How RYAN compares with its peers on the latest reported figures
- RYAN's LTM Jun 2026 investing cash flow of $247.02M is the 7th largest of the 9 companies compared; the peer median is $1.65B.
- Its year-over-year change of -88.4% is the 8th highest of 9, against a peer median of -19.9%.
- Investing cash flow amounts to 7.7% of revenue for RYAN, versus a peer median of 16.2%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jun 2026 | $3.97B | +5.2% | +9.2% | 20.7% | |
| LTM Jun 2026 | $3.92B | -1105.2% | -30.9% | 115.7% | |
| LTM Jun 2026 | $2.58B | -30.9% | -29.9% | 13.3% | |
| LTM Sep 2026 | $2.12B | +57.4% | +54.6% | 49.3% | |
| LTM Jun 2026 | $1.18B | -61.1% | -9.8% | 11.0% | |
| LTM Jun 2026 | $718M | -8.9% | -11.1% | 19.1% | |
| LTM Jun 2026 | $247.02M | -88.4% | +233.8% | 7.7% | |
| LTM Sep 2026 | $118.34M | +4.7% | -17.8% | 9.9% | |
| LTM Sep 2026 | $99.86M | -54.8% | -27.1% | 7.2% | |
| Peer median (excluding RYAN) | $1.65B | -19.9% | -14.4% | 16.2% | |
Competitors are the stored peer set for RYAN. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | 56.63M | 163.26M | 194.48M | 229.91M | 214.16M |
| Depreciation & Amortization | 112.68M | 109.29M | 115.84M | 167.63M | 287.52M |
| Deferred Income Tax | (1.15M) | 14.54M | 36.66M | 24.22M | 26.05M |
| Stock-Based Compensation | 67.53M | 77.48M | 69.74M | 79M | 38.78M |
| Change in Working Capital | (29.44M) | (74.99M) | 37.9M | (29.38M) | (37.28M) |
| Accounts Receivables | (29.66M) | (20.37M) | (44.19M) | (22.01M) | (57.56M) |
| Inventory | 0 | 0 | 0 | 0 | 0 |
| Accounts Payables | 0 | 0 | 0 | 0 | 0 |
| Other Working Capital | 220K | (54.62M) | 82.08M | (7.37M) | 20.28M |
| Other Non-Cash Items | 67.24M | 45.94M | 22.59M | 43.49M | 114.45M |
| Operating Cash Flow | 273.49M | 335.51M | 477.2M | 514.87M | 643.67M |
| Capital Expenditures | (9.78M) | (15.04M) | (29.78M) | (47M) | (67.95M) |
| Acquisitions (Net) | (108.88M) | 0 | (446.68M) | (1.71B) | (746.49M) |
| Purchases of Investments | 0 | 0 | 0 | 0 | (16.56M) |
| Sales of Investments | 0 | 0 | 0 | 0 | 0 |
| Other Investing Activities | (339.27M) | (7.38M) | 228K | 0 | (3.01M) |
| Investing Cash Flow | (457.94M) | (22.42M) | (476.23M) | (1.76B) | (834.01M) |
| Debt Repayment | (17.74M) | 377.46M | (16.5M) | 1.29B | 54.4M |
| Common Stock Issued | 1.45B | 0 | 0 | 0 | 0 |
| Common Stock Repurchased | (967.85M) | (7.17M) | (8.79M) | (2.13M) | (3.73M) |
| Dividends Paid | (47.1M) | (39.88M) | 0 | (80.24M) | (62.34M) |
| Other Financing Activities | 92.12M | (15.66M) | 12.68M | (37.55M) | 89.79M |
| Financing Cash Flow | 429.28M | 314.76M | (12.61M) | 1.17B | 78.12M |
| Effect of Forex Changes | (883K) | (126K) | 584K | (1.51M) | 15.9M |
| Net Change in Cash | 243.96M | 627.72M | (11.05M) | (75.53M) | (96.34M) |
| Free Cash Flow | 263.71M | 320.47M | 447.43M | 467.87M | 575.71M |
Ryan Specialty Holdings, Inc.
NYSE:RYAN
Intrinsic Alpha fair value
Locked
Current Price
$48.38
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.